Efficacy and Safety Study of 1.62% Testosterone Gel for the Treatment of Hypogonadal Men

  • Kaufman J
  • Miller M
  • Garwin J
 et al. 
  • 39


    Mendeley users who have this article in their library.
  • 40


    Citations of this article.


INTRODUCTION: Male hypogonadism is a significant and growing problem that can be successfully treated with testosterone replacement therapy. A new formulation of testosterone gel (1.62%) was developed with increased viscosity, reduced volume of application, and increased skin permeation compared with other currently available testosterone gels. AIM: To evaluate the efficacy and safety of titrated doses of 1.62% testosterone gel after daily application to the skin of hypogonadal men for 182 days. METHODS: This was a multicenter, randomized, double-blind, placebo-controlled study in hypogonadal men (234 active; 40 placebo), 18 to 80 years of age with average serum total testosterone concentrations

Author-supplied keywords

  • 1.62% Testosterone Gel
  • Androgens
  • Hypogonadism
  • Pharmacodynamics
  • Pharmacokinetics
  • Testosterone replacement therapy

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text


  • Joel M. Kaufman

  • Michael G. Miller

  • Jeffrey L. Garwin

  • Sherahe Fitzpatrick

  • Cecilia Mcwhirter

  • John J. Brennan

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free